v3.25.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2025
Summary of Significant Accounting Policies  
Schedule of company’s revenue disaggregated by category and source

 


Three Months Ended March 31,

 


2025


2024

 


(in thousands)

Commercial


$ 932

$ 1,041

Government contracts



607


5

Total revenue


$ 1,539


$ 1,046
Schedule of stock-based compensation included in cost of goods sold, research and development, and selling, general and administrative expenses

 


Three Months Ended March 31,

 


2025


2024

 


(in thousands)

Cost of goods sold


$ 237

$ 150

Research and development



1,043



1,431

Selling, general and administrative



3,044



2,663

Total stock-based compensation expense


$ 4,324

$ 4,244

Schedule of diluted weighted average shares

 


Three Months Ended March 31,

 


2025


2024

 


(in thousands, except per share amounts)


Numerator









Net loss attributable to common stockholders


$ (58,579
)
$ (31,610
)

 









Denominator









Weighted average shares – basic and diluted



131,104


111,061
Basic and diluted loss per share
$ (0.45 )
$ (0.28 )
Schedule of anti-dilutive unvested restricted stock units and unvested restricted stock awards

 


Three Months Ended March 31,

Antidilutive Shares Excluded


2025
2024

 


(in thousands)

Warrants



37,297


44,268

Stock Options



4,144


4,702

Unvested Restricted Stock Units



4,465


5,844

Unvested Restricted Stock Awards



231



345
2028 Notes Convertible Stock

15,127



Schedule of goodwill activities

 


Three Months Ended March 31,

 


2025

2024

 


(in thousands)

Beginning Balance


$ 16,966

$ 17,977

Changes in foreign exchange rates



675

(396 )

Ending Balance


$ 17,641

$ 17,581